Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
3.18 (1y: -35%)
Market Cap 61 M P/E(ttm)
Enterprise Value 27.65 M P/B 3.07
LCAV- NAS (USA)
LCA-Vision, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$3.18
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry		 vs
history
Cash to Debt 11.398
LCAV's Cash to Debt is ranked lower than
806451% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 0.24 vs. LCAV: 11.398 )
LCAV' s 10-Year Cash to Debt Range
Min: 2.46   Max: No Debt
Current: 11.4
Equity to Asset 0.404
LCAV's Equity to Asset is ranked lower than
1234567% of the 81 Companies
in the Global Medical Care industry.

( Industry Median: 0.49 vs. LCAV: 0.404 )
LCAV' s 10-Year Equity to Asset Range
Min: 0.39   Max: 0.93
Current: 0.4
0.39
0.93
Interest Coverage No Debt
LCAV's Interest Coverage is ranked lower than
961538% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. LCAV: No Debt )
LCAV' s 10-Year Interest Coverage Range
Min: No Debt   Max: No Debt
Current: No Debt
F-Score: 2
Z-Score: 1.54
M-Score: -2.6
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry		 vs
history
Operating margin (%) -9.20
LCAV's Operating margin (%) is ranked lower than
952380% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 10.90 vs. LCAV: -9.20 )
LCAV' s 10-Year Operating margin (%) Range
Min: -28.2   Max: 25.4
Current: -9.2
-28.2
25.4
Net-margin (%) -8.4
LCAV's Net-margin (%) is ranked lower than
1041666% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 6.20 vs. LCAV: -8.4 )
LCAV' s 10-Year Net-margin (%) Range
Min: -34.3   Max: 25.2
Current: -8.4
-34.3
25.2
ROE (%) -43
LCAV's ROE (%) is ranked lower than
1052631% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 10.30 vs. LCAV: -43 )
LCAV' s 10-Year ROE (%) Range
Min: -66.1   Max: 34.7
Current: -43
-66.1
34.7
ROA (%) -17.4
LCAV's ROA (%) is ranked lower than
1041666% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 5.30 vs. LCAV: -17.4 )
LCAV' s 10-Year ROA (%) Range
Min: -54.1   Max: 24.7
Current: -17.4
-54.1
24.7
Revenue Growth (%) -6.3
LCAV's Revenue Growth (%) is ranked lower than
1612902% of the 62 Companies
in the Global Medical Care industry.

( Industry Median: 6.00 vs. LCAV: -6.3 )
LCAV' s 10-Year Revenue Growth (%) Range
Min: -22.4   Max: 25.4
Current: -6.3
-22.4
25.4
EBITDA Growth (%) -33.1
LCAV's EBITDA Growth (%) is ranked lower than
2325579% of the 43 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. LCAV: -33.1 )
LCAV' s 10-Year EBITDA Growth (%) Range
Min: -51.5   Max: 238.6
Current: -33.1
-51.5
238.6
EPS Growth (%) -29.2
LCAV's EPS Growth (%) is ranked lower than
2325579% of the 43 Companies
in the Global Medical Care industry.

( Industry Median: 11.80 vs. LCAV: -29.2 )
LCAV' s 10-Year EPS Growth (%) Range
Min: -29.2   Max: 42.2
Current: -29.2
-29.2
42.2
ยป LCAV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

LCAV Guru Trades in Q2 2012

Paul Tudor Jones 100,000 sh (New)
Pioneer Investments 709,130 sh (+21.69%)
Jim Simons 648,704 sh (+2.9%)
Julian Robertson 1,227,577 sh (-10.56%)
» More
Q3 2012

LCAV Guru Trades in Q3 2012

Paul Tudor Jones Sold Out
Julian Robertson 1,226,777 sh (-0.07%)
Pioneer Investments 694,385 sh (-2.08%)
Jim Simons 608,604 sh (-6.18%)
» More
Q4 2012

LCAV Guru Trades in Q4 2012

Jim Simons 629,758 sh (+3.48%)
Julian Robertson 1,226,777 sh (unchged)
Pioneer Investments 604,620 sh (-12.93%)
» More
Q1 2013

LCAV Guru Trades in Q1 2013

Jim Simons 679,104 sh (+7.84%)
Pioneer Investments Sold Out
Julian Robertson Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with LCAV

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Julian Robertson 2013-03-31 Sold Out 0.62%$2.8 - $3.55 $ 3.181%0
Julian Robertson 2010-09-30 Add 6.6%0.19%$3.97 - $5.55 $ 3.18-34%1614796
Julian Robertson 2010-06-30 Add 27.29%0.39%$5.65 - $9.25 $ 3.18-59%1514796
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/B 3.07
LCAV's P/B is ranked lower than
847457% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 2.09 vs. LCAV: 3.07 )
LCAV' s 10-Year P/B Range
Min: 0.48   Max: 8.33
Current: 3.07
0.48
8.33
P/S 0.65
LCAV's P/S is ranked lower than
819671% of the 122 Companies
in the Global Medical Care industry.

( Industry Median: 0.98 vs. LCAV: 0.65 )
LCAV' s 10-Year P/S Range
Min: 0.19   Max: 6.32
Current: 0.65
0.19
6.32
EV-to-EBIT -2.3
LCAV's EV-to-EBIT is ranked lower than
862068% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 14.10 vs. LCAV: -2.3 )
LCAV' s 10-Year EV-to-EBIT Range
Min: 0.6   Max: 174.5
Current: -2.3
0.6
174.5
Shiller P/E 120.4
LCAV's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Care industry.

( Industry Median: vs. LCAV: 120.4 )
LCAV' s 10-Year Shiller P/E Range
Min: 1.83   Max: 874
Current: 120.4
1.83
874

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 11.4
LCAV's Price/Net Cash is ranked lower than
6249994% of the 16 Companies
in the Global Medical Care industry.

( Industry Median: 16.30 vs. LCAV: 11.4 )
LCAV' s 10-Year Price/Net Cash Range
Min: 2.4   Max: 82.1
Current: 11.4
2.4
82.1
Price/Net Current Asset Value 22.8
LCAV's Price/Net Current Asset Value is ranked lower than
1041666% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 14.00 vs. LCAV: 22.8 )
LCAV' s 10-Year Price/Net Current Asset Value Range
Min: 9.3   Max: 61.7
Current: 22.8
9.3
61.7
Price/Tangible Book 3
LCAV's Price/Tangible Book is ranked lower than
1282050% of the 78 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. LCAV: 3 )
LCAV' s 10-Year Price/Tangible Book Range
Min: 0.8   Max: 7.1
Current: 3
0.8
7.1
Price/DCF (Projected) 2
LCAV's Price/DCF (Projected) is ranked lower than
445% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 0.90 vs. LCAV: 2 )
LCAV' s 10-Year Price/DCF (Projected) Range
Min: 0.2   Max: 4.5
Current: 2
0.2
4.5
Price/Median PS Value 0.4
LCAV's Price/Median PS Value is ranked lower than
819671% of the 122 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. LCAV: 0.4 )
LCAV' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 4.3
Current: 0.4
0.3
4.3
Earnings Yield (Greenblatt) 16.60
LCAV's Earnings Yield (Greenblatt) is ranked lower than
854700% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. LCAV: 16.60 )
LCAV' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.6   Max: 162.5
Current: 16.6
0.6
162.5
Forward Rate of Return (Yacktman) -3.14
LCAV's Forward Rate of Return (Yacktman) is ranked lower than
1923075% of the 52 Companies
in the Global Medical Care industry.

( Industry Median: 11.73 vs. LCAV: -3.14 )
LCAV' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.3   Max: 118.1
Current: -3.14
-1.3
118.1

Business Description

LCA-Vision, Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. Its vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. Its vision centers are supported by independent, board-certified ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in its vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. It provides mainly two types of procedures in its vision centers: LASIK; and PRK and Surface Ablation. In 1996, it began performing LASIK, which continues to account for the majority of the laser vision correction procedures performed in the United States. In LASIK procedures, its surgeon's uses a femtosecond laser to create a thin flap, which remains hinged to the eye. In PRK procedures, the ophthalmologist removes the thin layer of cells covering the outer surface of the cornea (the epithelium) in order to apply the excimer laser pulses directly to the surface of the cornea. Following the PRK procedure, the ophthalmologist places a bandage contact lens on the eye to protect it. Most of its patients currently receive a procedure called laser-assisted in situ keratomileusis ("LASIK"), which it began performing in the United States in 1996. As of December 31, 2011, it operated 53 LasikPlus fixed-site laser vision correction centers generally located in metropolitan markets in the United States, including two vision centers licensed to ophthalmologists who operate using its trademarks. It currently uses two suppliers for its fixed-site excimer lasers: Abbott Medical Optics ("AMO") and Alcon Inc. ("Alcon"). Its business is heavily dependent on advertising, which is subject to regulation by the Federal Trade Commission ("FTC").
Company Website
SEC Reports
Industry: Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF
ยป More Articles for LCAV

Headlines

Articles On GuruFocus.com
LCAVision Inc. Reports Operating Results (10-Q) Oct 26 2010 
New Guru Added: Julian Robertson of Tiger Management; Buys CRME, EBAY, GOOG, ITUB, TWC Aug 30 2010 
LCAVision Inc. Reports Operating Results (10-Q) Apr 27 2010 
LCAVision Inc. Reports Operating Results (10-Q) Oct 27 2009 
A Case for LCA-Vision Inc. Oct 27 2009 
LCAVision Inc. Reports Operating Results (10-Q) Jul 28 2009 
LCAVision Inc. Reports Operating Results (10-Q) Apr 28 2009 
LoJack Corp.(LOJN) Rides High Feb 26 2009 
LCAVision Inc. (LCAV) SVP of Finance and CFO Michael J Celebrezze buys 2,800 Shares Feb 23 2009 
LCAVision Inc. (LCAV) CEO Steven C Straus buys 9,000 Shares Feb 23 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial